KYNTRA BIO, INC. Other Non-Current Liabilities
KYNTRA BIO, INC. (KYNB) had Other Non-Current Liabilities of $67.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-13
- 2026-06-30: Other Liabilities, Noncurrent $67.00K.
- 2026-03-31: Other Liabilities, Noncurrent $76.00K.
- 2025-12-31: Other Liabilities, Noncurrent $82.00K.
- 2025-09-30: Other Liabilities, Noncurrent $98.00K.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $67.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $76.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $82.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $98.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $106.00K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $830.00K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $822.00K 10-K · filed 2026-03-16 | |
| 2024-09-30 | $837.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.01M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $3.79M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $2.86M 10-K · filed 2025-03-17 | |
| 2023-09-30 | $4.25M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $4.96M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $7.06M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $6.44M 10-K · filed 2024-02-26 | |
| 2022-09-30 | $14.30M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $17.83M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $24.33M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $26.02M 10-K · filed 2023-02-27 | $26.02M 10-K · filed 2022-02-28 |
| 2021-09-30 | $24.32M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $30.66M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $38.34M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $38.79M 10-K/A · filed 2022-03-04 | $39.64M 10-K · filed 2021-03-01 |
| 2020-09-30 | $37.64M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $127.24M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $89.12M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $65.41M 10-K · filed 2021-03-01 | $64.27M 10-K · filed 2020-03-02 |
| 2019-09-30 | $36.04M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $19.06M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $9.98M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $9.99M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $10.29M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $9.32M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $8.56M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $8.05M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $6.69M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $6.25M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $5.84M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $6.19M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $4.76M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $4.99M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $5.24M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $4.61M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $747.00K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $702.00K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $699.00K 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $696.00K 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |